Quest Diagnostics announced appointment of Michael Cole as vice president of health plans. He was most recently national vice president, employer and individual markets, leading a business segment representing 7.6 million covered members.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
138.3 USD | -1.38% |
|
+0.73% | +0.30% |
11/06 | Quest Diagnostics Completes Acquisition of PathAI Diagnostics From PathAI | MT |
11/06 | Quest Diagnostics Completes Acquisition of PathAI Diagnostics From PathAI | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.30% | 15.36B | |
+25.78% | 89.17B | |
-23.45% | 75.87B | |
+2.75% | 27.41B | |
-8.56% | 17.52B | |
+0.46% | 17.04B | |
+78.55% | 13.18B | |
+77.76% | 13.67B | |
-25.61% | 12.83B | |
+23.13% | 12.56B |
- Stock Market
- Equities
- DGX Stock
- News Quest Diagnostics Incorporated
- Quest Diagnostics Appoints Michael Cole as Vice President of Health Plans